Medeze Group PCL (BKK:MEDEZE) Other Financing: ฿-1.4 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:MEDEZE Medeze Group PCL BKK:MEDEZE
19 GF Score
Price ฿6.20
! 5 Warning Signs
View Full Analysis

What is Medeze Group PCL Other Financing?

Medeze Group PCL BKK:MEDEZE -1.59% 19 Other Financing is ฿-1.4 Mil as of Jun. 2026. GuruFocus rates BKK:MEDEZE with a GF Score™ of 19/100. The stock has 5 warning signs investors should review.

Medeze Group PCL's Other Financing for the three months ended in Jun. 2026 was ฿-4.0 Mil.

Medeze Group PCL's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was ฿-1.4 Mil.


Medeze Group PCL Other Financing Historical Data

* Premium members only.

The historical data trend for Medeze Group PCL's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medeze Group PCL Other Financing Chart

Medeze Group PCL Annual Data
Trend Dec23 Dec24 Dec25
Other Financing
-11.60 -13.40 -16.24

Medeze Group PCL Quarterly Data
Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -4.88 -3.79 -3.84 -3.92 -4.01
BKK:MEDEZE
19GF Score
Medeze Group PCL BKK:MEDEZE
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medeze Group PCL Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-1.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ฿-1.4 Mil mean?
Medeze Group PCL (BKK:MEDEZE) has a Other Financing of ฿-1.4 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Medeze Group PCL and its competitors.
Is Medeze Group PCL's Other Financing too high?
Medeze Group PCL's current Other Financing is ฿-1.4 Mil. Overall, Medeze Group PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medeze Group PCL's Other Financing compare to HCA and THC?
Medeze Group PCL's Other Financing of ฿-1.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Medeze Group PCL and its competitors. Medeze Group PCL's current Other Financing is ฿-1.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeze Group PCL stock overvalued right now?
Medeze Group PCL (BKK:MEDEZE) has a current Other Financing of ฿-1.4 Mil. The current Other Financing is ฿-1.4 Mil. Medeze Group PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Medeze Group PCL (BKK:MEDEZE), the current Other Financing is ฿-1.4 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medeze Group PCL Business Description

Address Phuttha Monthon Sai 4 Road, 28/9 Moo 8, Krathum Lom, Sam Phran, Nakhon Pathom, THA, 73220
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score

Get the complete analysis for BKK:MEDEZE

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿6.20
Price